<DOC>
	<DOCNO>NCT02232789</DOCNO>
	<brief_summary>The purpose study 1 ) evaluate abuse liability human pharmacology mephedrone oral administration 2 ) compare pharmacological effect mephedrone obtain administration oral 3,4-methylenedioxymethamphetamine ( MDMA , ecstasy ) .</brief_summary>
	<brief_title>Abuse Liability Human Pharmacology Mephedrone</brief_title>
	<detailed_description>Mephedrone new psychoactive substance ( NPS ) . At present , randomize control trial evaluate effect mephedrone human . The current body knowledge regard acute effect mephedrone base anecdotal , self-reported effect ( e.g . internet forum ) , case report , emergency room series fatality . The aim study 1 ) evaluate abuse liability human pharmacology mephedrone oral administration 2 ) compare pharmacological effect mephedrone obtain administration oral 3,4-methylenedioxymethamphetamine ( MDMA , ecstasy ) .</detailed_description>
	<mesh_term>Amphetamine-Related Disorders</mesh_term>
	<mesh_term>N-Methyl-3,4-methylenedioxyamphetamine</mesh_term>
	<mesh_term>Methamphetamine</mesh_term>
	<criteria>Understanding accept study procedure sign informed consent . Male adults volunteer ( 1845 year old ) . Clinical history physical examination demonstrate organic psychiatric disorder . The ECG general blood urine laboratory test perform study within normal range . Minor occasional change normal range accept , investigator 's opinion , consider current state art , clinically significant , lifethreatening subject interfere product assessment . These change nonrelevance justify write specifically . Recreational use amphetamine , ecstasy hallucinogen derivative , mephedrone cathinone least 6 occasion ( two previous year ) without serious adverse reaction . Extensive metabolizer intermediate metabolizer phenotype cytochrome P4502D6 ( CYP2D6 ) activity determine use dextromethorphan selective probe drug . The weight exceed 15 % ideal weight applies accord size 60 100 Kg . Minor variation accept normal limit , researcher consider clinically insignificant . . Daily consumption &gt; 20 cigarette &gt; 4 standard unit ethanol . Regular use drug month prior study session . The treatment single limited dos symptomatic medicinal product week prior study session reason exclusion calculate cleared completely day experimental session . Presence major psychiatric disorder . Present history abuse drug dependence ( except nicotine dependence ) . Past history drug dependence ( except nicotine dependence ) . Subjects past history drug abuse could include . Having suffer organic disease major surgery three month prior study start . Blood donation 12 week participation clinical trial drug previous 4 week . Subjects intolerance serious adverse reaction drug amphetamine , ecstasy hallucinogen derivative , mephedrone cathinone . History clinical evidence gastrointestinal , liver , renal disorder may lead suspect disorder drug absorption , distribution , metabolism excretion , suggest gastrointestinal irritation due drug . Subjects unable understand nature , consequence study procedure request follow . Subjects positive serology Hepatitis B , C HIV .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Mephedrone</keyword>
	<keyword>3,4-methylenedioxymethamphetamine</keyword>
	<keyword>Abuse liability</keyword>
	<keyword>Human Pharmacology</keyword>
</DOC>